Association between atherosclerosis and osteoporosis, the role of vitamin D

被引:63
作者
Stojanovic, Olivera Llic [1 ]
Lazovic, Milica [1 ]
Lazovic, Marko [2 ]
Vuceljic, Marina [3 ]
机构
[1] Inst Rehabil, Belgrade 11000, Serbia
[2] Clin Ctr Nis, Clin Cardiovasc Dis, Belgrade, Serbia
[3] Biochem Lab ALLABO, Belgrade, Serbia
关键词
vitamin D deficiency; low bone density; cardiovascular disease; fracture risk; BONE-MINERAL DENSITY; COA REDUCTASE INHIBITORS; 1,25-DIHYDROXYVITAMIN D-3; CARDIOVASCULAR-DISEASE; D DEFICIENCY; AORTIC CALCIFICATION; LIPID PROFILE; FRACTURE RISK; LIPOPROTEIN; CALCIUM;
D O I
10.5114/aoms.2011.22066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The latest data support the correlation of atherosclerosis and osteoporosis, indicating the parallel progression of two tissue destruction processes with increased fatal and non-fatal coronary events, as well as higher fracture risk. Vitamin D inadequacy associated with low bone mineral density increases fall and fracture risk, leads to secondary hyperparathyroidism, calcifies coronary arteries and significantly increases cardiovascular disease. Randomized clinical trial evidence related to extraskeletal vitamin D outcomes was limited and generally uninformative. A recent recommendation on vitamin D dietary requirements for bone health is 600 IU/d for ages 1-70 years and 800 IU/d for 71 years and older, corresponding to a serum 25-hydroxyvitamin D level of at least 20 ng/ml (50 nmol/l). Further large randomized controlled trials are needed to reassess laboratory ranges for 25-hydroxyvitamin D in both diseases, in order to avoid under- and over-treatment problems, and completely clarify the relationship between atherosclerosis and osteoporosis.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 82 条
[21]  
Christiansen C, 1990, Osteoporos Int, V1, P7
[22]  
Cooper C, 2005, PREVENTION TREATMENT, P1
[23]  
Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1
[24]   Bone metabolism and vascular calcification [J].
Danilevicius, C. F. ;
Lopes, J. B. ;
Pereira, R. M. R. .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2007, 40 (04) :435-442
[25]   IOF position statement: vitamin D recommendations for older adults [J].
Dawson-Hughes, B. ;
Mithal, A. ;
Bonjour, J. -P. ;
Boonen, S. ;
Burckhardt, P. ;
El-Hajj Fuleihan, Ghada ;
Josse, R. G. ;
Lips, P. ;
Morales-Torres, J. ;
Yoshimura, N. .
OSTEOPOROSIS INTERNATIONAL, 2010, 21 (07) :1151-1154
[26]   25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification [J].
de Boer, Ian H. ;
Kestenbaum, Bryan ;
Shoben, Abigail B. ;
Michos, Erin D. ;
Sarnak, Mark J. ;
Siscovick, David S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (08) :1805-1812
[27]  
Delmas P., 2005, PREVENTION TREATMENT, P57
[28]  
DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S
[29]   Oral statins and increased bone-mineral density in postmenopausal women [J].
Edwards, CJ ;
Hart, DJ ;
Spector, TD .
LANCET, 2000, 355 (9222) :2218-2219
[30]   Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study [J].
Garnero, P. ;
Munoz, F. ;
Sornay-Rendu, E. ;
Delmas, P. D. .
BONE, 2007, 40 (03) :716-722